SMi Group are thrilled to present the 8th annual conference in the industry leading series, Advances in Cell Based Assays, taking place on 10th & 11th November 2015 in Central London, UK.Due to improvements in detection technology and sensitivity in drug screening, recent reports predict the cell based assays market to reach $4.7 billion in 2016. With a fresh new agenda for 2015, Advances in Cell Based Assays arrives at the perfect time to expand scientific horizons in key topics such as drug toxicity testing, live imaging, 3D modelling, phenotype screening, formulation in assay development, plus much more!We have worked closely with a leading panel of experts such as AstraZeneca, GSK, Pfizer and Johnson & Johnson, to create a packed programme that has been tailored for an audience of professionals working in regenerative medicine using 3D cell based assays and high-throughput technologies.FEATURED SPEAKERS INCLUDE:Xavier Leroy, Associate Director, Actelion Pharmaceuticals - Conference ChairClare Gardner, Senior Scientist, PfizerRoderick Beijersbergen, Group Leader, Division of Molecular Carcinogenesis, Netherlands Cancer InstituteFarnaz-Fallah Arani, Senior Group Leader, UCBYolanda Chong, Principal Scientist, Johnson & JohnsonNariman Ansari, Project Leader, Buchmann Institute for Molecular Life Sciences (BMLS) - Goethe University FrankfurtHIGHLIGHTS:Discover pioneering 3D cell-based assays advancing reliable and physiologically- relevant in vivo data with HCS technologiesNew for 2015 - Next generation multidimensional fluorescence imaging and computational quantificationNew for 2015 - Learn high content, high throughput phenotypic platforms for neglected tropical diseases